0001181431-13-018836.txt : 20130326
0001181431-13-018836.hdr.sgml : 20130326
20130326163314
ACCESSION NUMBER: 0001181431-13-018836
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130320
FILED AS OF DATE: 20130326
DATE AS OF CHANGE: 20130326
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 1550 E GUDE DR
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 1550 E GUDE DR
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIGHAM MICHAEL
CENTRAL INDEX KEY: 0001216917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 13717227
MAIL ADDRESS:
STREET 1: 890 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
rrd375105.xml
X0306
4
2013-03-20
0
0001356576
SUPERNUS PHARMACEUTICALS INC
SUPN
0001216917
BIGHAM MICHAEL
C/O ABINGWORTH MANAGEMENT INC
890 WINTER STREET, SUITE 150
WALTHAM
MA
02451
1
0
0
0
Common Stock
2013-03-20
4
P
0
5000
5.172
A
5000
I
By Beatrice Emerson Bigham Trust U/A DTD 2/28/2001
Common Stock
2013-03-20
4
P
0
5000
5.195
A
5000
I
By Cabot Forbes Bigham Trust U/A DTD 10/11/1996
Common Stock
2013-03-20
4
P
0
10000
5.264
A
10000
I
By Michael F Bigham CRUT U/A DTD 11/23/1994
Common Stock
2013-03-22
4
P
0
15000
5.653
A
25000
I
By Michael F Bigham CRUT U/A DTD 11/23/1994
Director Stock Option (Right to Buy)
7.90
2014-02-05
2023-02-05
Common Stock
8722
8722
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.11 to $5.20, inclusive. The Reporting Person undertakes to provide to any security holder of Supernus Pharmaceuticals Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) through (4).
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.17 to 5.20, inclusive.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.18 to 5.49, inclusive.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.53 to 5.68, inclusive.
/s/ Gregory S. Patrick, as attorney-in-fact
2013-03-26